NCI Standard Funding Opportunity Announcements
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
Ongoing |
All Ranks |
Federal |
See BAA |
Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
The purpose of this BAA is to solicit research proposals in the
engineering, physical, life, and information sciences for
submission to the Army Research Office (ARO) for consideration
for possible funding.
Due Dates: |
Open until March 31, 2017
Proposers are to submit white papers prior to submission of a
complete proposal. Based on assessment of white papers, feedback will be
provided to encourage or discourage submission of full proposals. |
Amount & Project Period: |
No specific dollars have been reserved 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Links: |
ARO CORE
BAA-W911NF-12-R-0012-Mod 03
|
|
NEW |
Ongoing |
All Ranks |
Non-federal |
Macroglobulinemia |
International Macroglobulinemia Foundation
Research Grants
To further scientific knowledge of the cause, diagnosis,
treatment, or cure for the disease Waldenstrom's
Macroglobulinemia, a type of non-Hodgkin's Lymphoma also called
lymphoplasmacytic lymphoma.
Due Dates: |
Ongoing |
Amount & Project Period: |
$50,000 to $100,000 - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Guidelines |
|
New FOA number |
October 1 through December 01 |
See below |
Federal |
Career Development |
Research
Supplements to
Promote Re-Entry
into Biomedical
and Behavioral
Research Careers
Supports
individuals with
high potential
to re-enter a
research career
after an
interruption
Funding is
provided to
existing NIH
research grants
for the purpose
of supporting
full-time or
part-time
research by
these
individuals to
update their
existing
research skills
and knowledge.
Due Dates: |
For NCI: Applications
accepted from Oct 01 to Dec 01. Proposals must be delivered to OSR a
minimum of 2 days prior to submission. |
Amount & Project Period: |
Requested salary and fringe benefits for a
re-entry candidate must be in accordance w/salary structure of the
grantee institution, consistent w/level of effort. An additional $10,000
may be requested for other relevant costs. |
Eligibility: |
Research proposed for supplement must be
accomplished w/in the competitive segment of the active award. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-321 |
|
New FOA Number |
October 1 through December 01 |
See Below |
Federal |
Career Development |
Research
Supplements to
Promote
Diversity in
Health-Related
Research
Administrative supplements to improve diversity of research workforce by
recruiting and
supporting
students,
postdoctorates,
and eligible
investigators
from groups that
have been shown
to be
underrepresented
in
health-related
research.
Due Dates: |
For NCI: Applications accepted
from Oct 01 to Dec 01. Proposals must be delivered to OSR a minimum of 2
days prior to submission. |
Amount & Project Period: |
Limited to no more than the amount of current
parent award, and must reflect actual needs of the proposed project
For NCI: Annual Salary Cap for Investigators Developing
Independent Research Careers: $75,000 plus fringe benefits |
Eligibility: |
Parent award must be active and research
proposed must be accomplished within the competitive segment. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-322 |
|
|
October 01 |
PostDocs |
Non-federal |
Career Development |
Cancer
Research
Institute
Postdoctoral
Fellowship
Cancer immunology fellowship seeks hypothesis driven, mechanistic
studies in both
immunology and
tumor
immunology. Applicant and
sponsor must
clearly state
potential of
proposed studies
to directly
impact
understanding of
the immune
system's role in
cancer risk,
tumor
initiation,
progression,
metastasis, host
response to
tumors and/or
the treatment of
cancer.
Due Dates: |
Sept 29 (OSR) - Oct 01 (Sponsor) |
Amount & Project Period: |
Stipend:
$50,000,
year 01;
$53,000, year 02;
$57,000, year 03.
Allowance: $1,500/year for use at sponsor's discretion to help pay for fellow's
research supplies, travel to scientific meetings, and/or health
insurance. |
Eligibility: |
Must be working in areas directly related to
cancer immunology
Must have doctoral degree by award activation
One fellow per sponsor may apply per application round
No citizenship restrictions |
Contact: |
Linda
Nolan (x6071) |
Link: |
Postdoctoral
Fellowship Application Guidelines |
|
|
October 01 |
Postdocs |
Non-federal |
Career Development |
Life
Sciences
Research
Foundation
Postdoctoral
Fellowship
Supports training in all areas of the life sciences. System opens on
September 09 for
new applications.
Due Dates: |
Oct 01 |
Amount & Project Period: |
$60,000/yr - 3 years |
Eligibility: |
Individuals who have held a PhD or MD degree
for less than 5 years at the time of application are eligible |
Contact: |
Linda
Nolan (6071) |
Link: |
Application
Instructions |
|
NEW |
October 01 |
All Ranks |
Non-federal |
Research Support |
Elsa U.
Pardee
Foundation
Research
Grants
Funds research
directed toward
identifying new
treatments or
cures for
cancer.
Particularly
encouraged are
grant allowing
establishment of
capabilities of
new cancer
researchers, or
new cancer
approaches by
established
cancer
researchers.
|
NCI is a participating Institute
NEW |
October 05 |
All Ranks |
Federal |
Palliative Care/AYA |
End-of-Life
and Palliative
Needs of
Adolescents and
Young Adults
(AYA) with
Serious
Illnesses
Fosters research on the unique perspectives, needs, wishes, and
decision-making
processes of
adolescents and
young adults
(AYA - youth
between 12 - 24
years of age)
w/serious,
advanced
illnesses; and
research focused
on specific
end-of-life/palliative
care (EOLPC)
models that
support
physical,
psychological,
spiritual, and
social needs of
AYA with serious
illness, their
families and
caregivers.
Due Dates: |
Standard Dates
Proposals required to be at OSR 2 business days
prior to due date.
|
Amount & Project Period: |
R01: Budget not limited - 5 years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (6071) |
FOA Links: |
R01:
PPA-15-324 Ι R21:
PA-15-325 |
|
NCI is a participating institute
|
October 05 |
All Ranks |
Federal |
SGM Populations |
The Health
of Sexual and
Gender Minority
(SGM)
Populations
Supports research to increase scientific understanding of the health
status of
diverse
population
groups and
thereby improve
effectiveness of
health
interventions
and services for
individuals
within those
groups.
Priority is
placed on
understudied
populations with
distinctive
health risk
profiles.
Due Dates: |
Standard dates
Proposals required to be at OSR 2 business
days prior to due date. |
Amount & Project Period: |
R01: Budgets not limited -
5 years
R21: $275,000 (Direct Costs) - 2 years
R03: $100,000 (Direct Costs) - 2 years
R15: $300,000 (Direct Costs) - 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Links: |
PA-15-261 - R01
PA-15-263 - R21
PA-15-262 - R03
PA-15-260 - R15 Academic Research Enhancement Award |
|
New FOA Numbers |
October 05 |
All Ranks |
Federal |
Physical Activity & Weight Control |
Physical
Activity and
Weight Control
Interventions
Among Cancer
Survivors:
Effects on
Biomarkers of
Prognosis and
Survival
Encourages
transdisciplinary
and
translational
research that
will identify
the specific
biological or
biobehavioral
pathways through
which physical
activity and/or
weight control
(either weight
loss or
avoidance of
weight gain) may
affect cancer
prognosis and
survival.
Due Dates: |
Standard dates
Proposals required to be at OSR 2 business
days prior to due date. |
Amount & Project Period: |
R01: Budget not limited - 5 years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (X6071) |
FOA Links: |
R01:
PA-15-311
R21:
PA-15-310 |
|
|
October 07 |
See Below |
Federal |
Supplemental Funding |
Assay
Validation For
High Quality
Markers For
NCI-Supported
Clinical Trials
To improve the
development and
validation of
molecular
diagnostics for
the treatment,
control, or
prevention of
cancer.
Due Dates: |
Oct 05 (OSR) - Oct 07 (Sponsor) |
Amount & Project Period: |
Limited to $150,000 in direct costs in any
single year
May not exceed 3 years |
Eligibility: |
Must hold active grant or cooperative
agreement, and research proposed for supplement must be accomplished
within the competitive segment of the active award. |
Contact: |
Linda
Nolan (X6071) |
FOA Link: |
PA-15-264 |
|
Division of Program Coordination, Planning and Strategic
Initiatives,
Office of Strategic Coordination (Common
Fund)
|
October 09 |
All Faculty |
Federal |
Career Development |
NIH Pioneer
Award Program
This award
complements
NIH's
investigator-initiated
grant programs
by supporting
individual
scientists of
exceptional
creativity who
propose
pioneering and
possibly
transforming
approaches to
addressing major
biomedical or
behavioral
challenges
having potential
to produce an
unusually high
impact on a
broad area of
biomedical or
behavioral
research.
Proposed
research must
reflect
substantially
different
scientific
directions from
those already
being pursued in
the
investigator's
research program
or elsewhere.
Due Dates: |
Oct 07 (OSR) - Oct 09 (Sponsor) |
Amount & Project Period: |
$700,000/yr (Direct Costs) - 5 years |
Eligibility: |
All Faculty - Single PD/PI applications only |
Contact: |
Linda
Nolan (X6071) |
RFA Link: |
RFA-RM-13-006 |
|
|
October 12 (LOI) |
All Faculty |
Non-federal |
Melanoma |
Melanoma
Research
Alliance (MRA)
Team Science
Awards
Special Emphasis Areas:
1) Define logical and
optimal
combination
therapies,
therapeutic
sequences, or
treatment
regimens;
2)
Biomarkers of
risk of
recurrence or
death in early
stage disease to
speed
development of
adjuvant
therapies;
3)
Research leading
to improvements
in
difficult-to-treat
disease or
treatment
failures;
4) Improving
understanding of
biological basis
for melanoma
formation.
Due Dates: |
Oct 12 (Letter of Intent)
Invited Applications: Jan 06 (OSR) - Jan 08
(Sponsor) |
Amount & Project Period: |
$900,000 - 3 years |
Eligibility: |
Assistant Professor (or equivalent) or above.
Multidisciplinary teams of two or more established Principal
Investigators and a Young Investigator with complementary expertise. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015-2016 Request for Proposals |
|
NCI is a participating Institute
|
October 13 (LOI) |
All Ranks |
Federal |
Tobacco Research |
Chemistry,
Toxicology, and
Addiction
Research on
Waterpipe
Tobacco
Research that will inform the development and evaluation of possible
regulatory
action on
waterpipe (or
hookah) tobacco
products.
Due Dates: |
Oct 13 (Letter of Intent)
Although letters of intent are typically requested 1 month prior to the
submission due date, letters of intent for this FOA are requested on Oct 13
Application: Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
Not to exceed $300,000/yr (Direct Costs) - 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-OD-15-005 |
|
Annual Deadline |
October 15 |
See Below |
Non-Federal |
See Below |
American Cancer
Society
Due Dates: |
Oct 13 (OSR) - Oct 15 (Sponsor)
NOTE: Paper copies are due one day after submission of the electronic
copy. |
Contact: |
Linda
Nolan (X6071) |
|
|
Research and
Training Grants
- Career
Development
Amount & Project Period: |
Research Scholar
Grants: $165,000/yr (Direct Costs) - 4 years
Postdoctoral Fellowships:
Progressive stipends of $48,000, $50,000, and $52,000, plus a $4,000/yr
fellowship allowance Mentored Research
Scholar Grants: $135,000/yr - 5 years |
Eligibility: |
See specifics in Program Announcement |
PA Links: |
Independent Investigators: Research
Scholar Grants
Mentored Research Grants:
Postdoctoral Fellowships &
Mentored Research Scholar Grant
Submission Portal:
proposalCENTRAL |
|
Current RFA |
Pilot
and Exploratory
Projects in
Palliative Care
of Cancer
Patients and
Their Families
Funding for investigators performing pilot and exploratory research
studies whose
purpose is to
test
interventions,
develop research
methodologies,
and explore
novel areas of
research in
palliative care
of cancer
patients and
their families.
A condition of
funding is a
clearly defined
plan as to how
the investigator
will use the
results of the
project to
develop larger,
extramurally
funded research
projects.
|
Current RFA |
The Role
of Health Policy
and Health
Insurance in
Improving Access
to and
Performance of
Cancer
Prevention,
Early Detection,
and Treatment
Services
Research focus
on changes in
national, state,
and/or local
policy and
response to
these changes by
healthcare
systems,
insurers,
payers,
communities,
practices, and
patients.
Amount & Project Period: |
Dependent on award period requested:
$200,000/yr (direct Costs - < 4 years
$165,000/yr (Direct Costs) - 4 years
$200,000/yr (Direct Costs)
- 5
years |
Eligibility: |
Independent investigators at all career stages |
RFA Link: |
Award Overview
Research Scholar Grants Policies and Instructions (Award funded
under Research Scholar mechanism)
Submission Portal:
proposalCENTRAL |
|
NCI is a participating institute
|
October 15 |
See Below |
Federal |
Supplemental Funding |
Administrative
Supplements for
Research on
Dietary
Supplements
To support
research in
which the
supplemental
funding would
investigate the
role of dietary
supplements
and/or their
ingredients in
health
maintenance and
disease
prevention.
Due Dates: |
Oct 13 (OSR) - Oct 15 (Sponsor) |
Amount & Project Period: |
$100,000 (Total Costs) - Limited to 1
year |
Eligibility: |
Active awards with at least 18 months remaining
at time of submission will be considered. Awards in no-cost extension
periods are not eligible. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-258 |
|
Division of Program Coordination, Planning and Strategic
Initiatives, Office of Strategic Coordination (Common
Fund)
|
October 16 |
Jr faculty |
Federal |
Career Development |
NIH
Director's New
Innovator Award
Program
This award
initiative
supports early
stage
investigators of
exceptional
creativity
proposing bold
and highly
innovative new
research
approaches that
have the
potential to
produce a major
impact on broad,
important
problems in
biomedical and
behavioral
research.
Due Dates: |
Oct 14 (OSR) - Oct 16 (Sponsor) |
Amount & Project Period: |
$300,000/yr (Direct Costs) - 5 years |
Eligibility: |
Applicants must meet the definition of an Early
Stage Investigator (ESI) Must hold an independent research position as
of Sept 01. Required to commit at least 25% research effort each
year to activities supported by this award |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-RM-13-007 |
|
|
October 17 (LOI) |
All Clinical Faculty |
Federal |
Imaging & Precision
Medicine |
Oncology
Co-Clinical
Imaging Research
Resources to
Encourage
Consensus on
Quantitative
Imaging Methods
and Precision
Medicine
Scientific Goals:
(a) Perform
appropriate
optimization of
pre-clinical
quantitative
imaging methods,
(b) Implement
optimized
methods in
co-clinical
trial,
(c) Populate a
web-accessible
research
resource with
all data,
methods,
workflow
documentation,
and results
collected from
the co-clinical
investigations.
Due Dates: |
Oct 17 (Letter of Intent)
Nov 15 (OSR) - Nov 17 (Sponsor) |
Amount & Project Period: |
$500,000/yr (Direct Costs) - 5 years |
Eligibility: |
All Clinical Faculty |
Contact: |
Linda
Nolan (X6071) |
FOA Link: |
PAR-15-266 |
|
|
October 18 |
See Below |
Federal |
Genomics |
Supplements
to Support
Evaluation of
the NCI Cancer
Genomics Cloud
Pilots
To support projects that will incorporate the use of one or more of the
NCI Cancer
Genomics Cloud
Pilots into
ongoing research
activities.
Due Dates: |
Oct 16 (OSR) - Oct
18 (Sponsor) |
Amount & Project Period: |
$40,000 (Direct Costs) Must be w/in currently
approved project period of existing parent award and work must be
completed no later than September 30, 2016. |
Eligibility: |
Announcement is for supplements to existing
projects (R01, R21, U01, U24).
Parent award must be active and research proposed in supplement must be
accomplished w/in competitive segment. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-305 |
|
|
October 20 (LOI) |
All Faculty |
Federal |
Informatics Technologies |
Advanced
Development of
Informatics
Technologies for
Cancer Research
and Management
Advanced development and enhancement of emerging informatics technologies
to improve the
acquisition,
management,
analysis, and
dissemination of
data and
knowledge across
the cancer
research
continuum,
including cancer
biology, cancer
treatment and
diagnosis,
cancer
prevention,
cancer control
and
epidemiology,
and/or cancer
health
disparities.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
Not to exceed $600,000/yr (Direct Costs) - 5
years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-331 |
|
|
October 20 (LOI) |
All Faculty |
Federal |
Informatics Technologies |
Early-Stage
Development of
Informatics
Technologies for
Cancer Research
and Management
For development of enabling informatics technologies to improve the
acquisition,
management,
analysis, and
dissemination of
data and
knowledge across
the cancer
research
continuum.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
$300,000/yr (Direct Costs) - 3 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-332 |
|
|
October 20 (LOI) |
All Faculty |
Federal |
Informatics Resources |
Sustained
Support for
Informatics
Resources for
Cancer Research
and Management
For continued development and sustainment of high-value informatics
research
resources to
serve current
and emerging
needs across the
cancer research
continuum.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-13-333 |
|
|
October 20 (LOI) |
All Ranks |
Federal |
Innovative Informatics |
Development
of Innovative
Informatics
Methods and
Algorithms for
Cancer Research
and Management
Encourages
applications
focused on the
development of
novel
computational,
mathematical,
and statistical
algorithms and
methods that can
considerably
improve
acquisition,
management,
analysis, and
dissemination of
relevant data
and/or
knowledge.
Due Dates: |
Oct 20 (Letter of Intent)
Nov 18 (OSR) - Nov 20 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
PAR-15-334 |
|
|
October 23 (LOI) |
All Ranks |
Federal |
Detection/Prevention/Risks |
Translational
Research on
Adducts in
Cancer Risk
Identification
and Prevention
Encourages clinically-relevant translational/epidemiological research
projects focused
on the use of
adducts to
cellular
macromolecules,
as indicators of
exposures to
cancer risk
factors in human
populations and
subgroups.
Priority is on
projects that
will focus on
adductomic
approaches,
i.e., address
some aspects of
the totality of
adducts. Main
emphasis is on
advancing the
area of cancer
detection,
cancer
prevention, and
assessing cancer
risks in human
populations and
subgroups.
Due Dates: |
Letter of Intent due 30 days prior to
application due date
Applications: Nov 21 (OSR) - Nov 23
(Sponsor) |
Amount & Project Period: |
U01 & R01: Budgets not limited - 5 years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Links: |
U01:
PAR-15-307
R01:
PAR-15-308
R21:
PAR-15-309 |
|
|
October 25 (LOI) |
All Faculty |
Federal |
Pancreatic |
The Pancreatic Cancer Detection Consortium
To establish the
Pancreatic
Cancer Detection
Consortium
(PCDC) to
conduct research
to improve
detection of
early stage
pancreatic
ductal
adenocarcinoma
(PDAC) and
characterization
of its precursor
lesions.
Intended to
support research
for development
and testing of
new molecular
and imaging
biomarkers for
identifying
patients at high
risk for PDAC
who could be
candidates for
early
intervention.
Due Dates: |
Oct 25 (Letter of Intent)
Nov 23 (OSR) - Nov 25 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-289 |
|
|
October 28 |
All Ranks |
Federal |
Physics/Cancer Biology |
National
Science
Foundation (NSF)
Directorate for
Mathematical &
Physical
Sciences
Division of
Physics
Investigator-Initiated
Research
Projects (PHY)
Physics of
Living Systems
Focus should be
on understanding
basic physical
principles that
underlie
biological
function.
From
Dear Colleague
Letter Below:
inter-
and
multi-disciplinary
research
at the
intersection of
physical and
life sciences
with a focus on
advancing the
fundamental
understanding of
cancer biology
to underpin
translational
research that
promotes the
prevention,
detection, and
treatment of
cancer diseases.
|
|
October 30 (LOI) |
All Ranks |
Federal |
Palliative Care |
Exploratory
Multi-site
Palliative Care
Research in
Diverse
Populations
Utilizing the
Palliative Care
Research
Cooperative
(PCRC) Group
For research that enhances the knowledge-base of palliative care science
across diverse
populations
receiving
end-of-life and
palliative care
(EOLPC) through
multi-site
clinical
research that
utilizes the
infrastructure
and resources of
the Palliative
Care Research
Cooperative
(PCRC) Group.
Due Dates: |
Oct 30 (Letter of Intent)
Nov 28 (OSR) - Nov 30 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-337 |
|
|
November 01 |
See Below |
Non-federal |
Desmoid Tumors |
Desmoid Tumor
Foundation
Due Dates: |
Oct 30 (OSR) - Nov 01
(Sponsor) |
Contact: |
Linda
Nolan (x6071) |
|
|
General
Research Grants
Funds research
using
cutting-edge
science and
creative
clinical
applications, in
addition to
novel approaches
addressing
potential leads
based on prior
research.
Researchers must
be willing to
collaborate with
other scientists
and institutions
with similar
interests.
Amount & Project Period: |
$65,000/year - a minimum of 1 year |
Eligibility: |
All Ranks |
Links: |
2015 RFP Ι
Research Grants |
|
|
New
Investigator
Research Grants
Funds early stage research to explore new approaches to advance current
scientific
knowledge about
desmoid tumors
This RFP seeks
applications
from young
investigators,
new to desmoid
tumor research
and in need of
seed funding to
gather
preliminary data
that will enable
applications for
funding to
support more
fully developed
lines of
research.
Amount & Project Period: |
$30,000/year - a minimum of 1 year |
Eligibility: |
Individuals with an academic rank of
Instructor, Assistant Professor or Associate Professor who have not
previously received funding for independent research directed at desmoid
tumors are encouraged to apply |
Link: |
New
Investigator RFP Ι
Research Grants |
|
|
November 01 (LOI) |
All Faculty |
Non-federal |
Immunotherapies |
Cancer
Research
Institute
Clinic and
Laboratory
Integration
Program
Provides funding
to explore
clinically
relevant
questions aimed
at improving the
effectiveness of
cancer
immunotherapies.
Supports basic,
pre-clinical,
and
translational
research, which
will provide
information that
can be directly
applied to
optimizing
cancer
immunotherapy in
the clinic.
Due Dates: |
Nov 01 (Letter of Intent)
Invited Applications: Jan 30 (OSR) - Feb 01 (Sponsor) |
Amount & Project Period: |
$100,000/year - 2 years |
Eligibility: |
Must hold faculty appointment as a tenure-track
assistant professor or higher at time of award activation.
CRI has no citizenship restrictions, |
Contact: |
Linda
Nolan (x6071) |
Link: |
CLIP Application Guidelines |
|
NEW |
November 03 |
All Ranks |
Non-federal |
Esophagus and Stomach |
6th Annual
DeGregorio
Foundation
Award for
Cancers of the
Esophagus and
Stomach
Seed funding for research in upper GI malignancies to promote and
facilitate
collaborative
research on the
pathogenesis,
early diagnosis,
and treatment of
upper
gastrointestinal
malignancies.
|
NEW |
November 03 (LOI) |
Jr faculty |
Non-federal |
Palliative Care |
National Palliative Care Research Center
Pilot and Exploratory Project Support Grant
Focus is on improving care for seriously ill patients and their families
must conduct research projects whose purpose is to test
interventions, develop research methodologies
Due Dates: |
Nov 03 (Letter of Intent)
Invited Applications: January 13 (OSR) January 15 (Sponsor) |
Amount & Project Period: |
$70,000 (Direct Costs) - 2 years |
Eligibility: |
Must have full-time faculty position or equiv
by award start Must be citizens/permanent residents of the United States
Should have minimum of 5 years postdoctoral experience. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
NPCRC Funding Opportunities |
|
|
November 16 |
Jr Faculty |
Non-federal |
Career Development |
Melanoma
Research
Alliance
Young
Investigator
Awards
To accomplish
innovative,
translational
research
projects.
Due Dates: |
Nov 14 (OSR) - Nov 16 (Sponsor) |
Amount & Project Period: |
$75,000/yr - 3 years |
Eligibility: |
Must be within 4 years of first independent,
full time academic faculty appointment
Applicants who have secured an independent full-time faculty position
commencing by July 1, 2016 will be considered (a letter from an
institutional official or department chairperson confirming date of
faculty appointment is required at time of application |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015-2016 Request for Proposals |
|
|
November 16 |
Established Faculty |
Non-federal |
Industry Partnerships |
Melanoma
Research
Alliance (MRA)
Established
Investigator
Academic-Industry
Partnership
Awards
Designed to
enhance
translational
research by
extending
academic
capabilities to
clinical
investigations
and to
facilitate
interactions
between academic
and industrial
research sectors
Awards will be
co-funded by MRA
and an industry
partner whose
involvement is
essential to the
project
Due Dates: |
Nov 14 (OSR) - Nov 16 (Sponsor) |
Amount & Project Period: |
$100,000/yr - 3 years (Industry funds and/or
in-kind support which must be at least 50% of the total support for the
project (e.g., reagents, clinical grade drugs, equipment, contract
services) must match but may exceed MRA funds for the award period. |
Eligibility: |
Established Investigators
Industry scientists may serve as co-investigators or collaborators, but
may not be PIs |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015-2016 Request for Proposals |
|
|
November
17 |
All Faculty |
Federal |
Co-Clinical Trials |
Oncology Co-Clinical Imaging Research Resources to Encourage
Consensus on Quantitative Imaging Methods and Precision Medicine
The purpose of this FOA is to develop research that will
encourage a consensus on how Quantitative Imaging (QI) methods
are optimized to improve correlation of results for co-clinical
trials; defined as investigations in patients and in parallel
(or sequentially) in mouse or human-in-mouse models of cancer
that mirror the genetics and biology of the patients'
malignancies or pre-cancerous lesions.
The scientific goals are to: (a) perform the appropriate
optimization of the pre-clinical quantitative imaging methods,
(b) implement the optimized methods in the co-clinical trial,
and finally (c) populate a web-accessible research resource with
all the data, methods, workflow documentation, and results
collected from the co-clinical investigations.
Applicants are encouraged to organize multi-disciplinary teams
with experience in mouse models research, human investigations,
imaging platforms, QI methods, decision support software and
informatics to populate the research resource.
Due Dates: |
Nov 10 (OSR) -
Nov 17 (Sponsor) |
Amount & Project Period: |
$500,000/year for 5 years |
Eligibility: |
All Faculty |
Contact: |
Contact Dr. Robert
Gillies |
FOA Link: |
PAR-15-266 |
|
NEW |
November 18 (Pre-application) |
All Ranks |
Federal |
Breast |
Breast Cancer Research Program
Breakthrough Award Levels 1 & 2
W81XWH-15-BCRP-BREAKTHROUGH2_FL12
Funding
Level 1: Innovative,
high-risk/high-reward research that is in the
earliest stages of idea development; Research
with potential to yield new avenues of
investigation; Proof of concept; No preliminary
data required
Funding
Level 2: Research that is
already supported by preliminary data and has
potential to make significant advancements
toward clinical translation; Demonstration of
efficacy in in vivo models, as applicable.
Due Dates: |
Nov 18 (Pre-app) Nov 30 (OSR) Dec
02 (Sponsor) |
Amount & Project Period: |
Funding Level 01: $375,000 – 3 years
Funding Level 02:
$750,000 – 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
Program Announcement |
|
NCI is a participating Institute
|
November 30 |
See Below |
Federal |
SGM Health - Supplement |
Administrative Supplements for Research on
Sexual and Gender Minority(SGM) Populations
To
expand existing research to focus on Sexual and
Gender Minority (SGM) health
Intended to encourage investigation in this
underrepresented growing field of research.
Supplement will focus on areas of specific
research interest beyond HIV/AIDS, including,
but not limited to: studies on increased disease
risk; behavioral and social health; approaches
to personalized medicine; access to care;
reproductive and sexual development; and
resilience.
Due Dates: |
Nov 28 (OSR) - Nov 30 (Sponsor) |
Amount & Project Period: |
No more than $100,000 (Total Costs) - Project
and budget periods must be w/in currently approved project period for
existing parent award. All awards are for a one-year period |
Eligibility: |
Only active awards with at least 18 months
remaining at submission will be considered. Awards in
no-cost extension periods are not allowed to submit an application
Only one application per parent award may be submitted |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-329 |
|
|
November 30 |
All Ranks |
Federal |
Computational
Mathematics |
Division of Mathematical Sciences
Computational Mathematics
Supports mathematical research in areas of
science where computation plays a central and
essential role, emphasizing analysis,
development and implementation of numerical
methods and algorithms, and symbolic methods
Due Dates: |
Nov 28 (OSR) - Nov 30 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - generally 1- 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
PA Link: |
PD 16-1271 |
|
NEW |
December 01 |
All Ranks |
Non-federal |
Breast |
Earlier.Org
Pilot Projects
New methods to improve detection of early breast
cancer and development of new techniques in
areas of biological or immunologic methods of
early detection. Should represent a new
approach to the area of interest and cannot
enhance ongoing research unless it is clear that
a new line of inquiry is being explored.
Due Dates: |
Nov 25 (OSR) - Dec 01 (Sponsor) |
Amount & Project Period: |
$40,000 (Total) 1-3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Pilot Projects |
|
NEW |
December 14 |
See Below |
Non-federal |
Interventional Radiology |
Society for Interventional Radiology (SIR)
|
|
Dr. Ernest J. Ring Academic Development
Grant
Provides support to junior Interventional Radiology faculty members early
in careers to allow time for the conduct of
research.
Amount & Project Period: |
$50,000/yr - 2 years |
Eligibility: |
Jr full-time faculty members, w/MD, DO, PhD, or
equivalent degree, not recognized as independent w/in 1st 5 years of
initial faculty appointment. |
|
|
Pilot Research Grant
Typically pilot or seed grant-type projects
testing a new idea.
Amount & Project Period: |
$25,000/yr - 1 year |
Eligibility: |
Must be active members of SIR
Fulltime interventional radiology
faculty and trainees Postdoctoral
candidates are invited to apply |
|
|
Allied Scientist Training Program
Priority areas include:
Tumor and Microenvironment Biology
Biomarker Development
Genetics
Imaging
Therapy
Amount & Project Period: |
$20,000/yr - 2 years |
Eligibility: |
Trainees enrolled in graduate level, degree
seeking programs (Masters, Doctor of Philosophy or equivalent) |
|
|
December 16 |
All Faculty |
Federal |
Collaborative/Translational
Research |
Pre-application: Opportunities for
Collaborative Research at the NIH Clinical
Center
To
accelerate and enhance translational science by
promoting partnerships between NIH intramural
investigators (e.g., those conducting research
w/in labs and clinics of the NIH) and
extramural investigators. NCI encourages
bench-to-bedside research to: increase
understanding of molecular and physiological
basis of health and disease; stimulate clinical
discoveries about mechanisms underlying disease
to develop improved prevention, diagnosis, and
treatment; enable translation of basic
discoveries into clinical practice; foster
training and mentoring of emerging scientists
and physicians; and communicate research
advances to public.
Due Dates: |
Dec 14 (OSR) - Dec 16 (Sponsor) |
Amount & Project Period: |
N/A - pre-application only |
Eligibility: |
All Faculty - Must include at least 1 intramural scientist as
Program Director/Principal Investigator or collaborator, and at least
some of the research must be conducted at the NIH Clinical Center. |
Contact: |
Linda Nolan
(x6071) |
FOA Link: |
PAR-15-286 |
|